Summary
NeuroSearch new drug NSD-721 will be of great benefit to patients with Social Anxiety Disorder.
Analysis
Social anxiety disorder is often under diagnosed and undertreated just by the very fact that these patients are shy and reluctant to discuss their illness. The currently approved products for Social anxiety disorder such as Luvox CR, Paxil, and effexor XR have shown some success but NSD-721 looks like it may be very helpful with minimal side effects.
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
